MicroRNA expression in chronic Hepatitis C patients treated with combined pegylated interferon alpha and ribavirin therapy
Last updated: 03 Jan 2025
10.21608/besps.2016.8644
miRNA, Chronic HCV, Combination therapy
Awad
El-abd
Departments of Medical Biochemistry,and Biochemical Endocrinology Unit, Faculty of Medicine, Benha University, Egypt
Magdi
El-sadek
Hepatology, Gastroenterology and Infectious Diseases,Faculty of Medicine, Benha University, Egypt.
Inas
Ahmed
A.
Department of Medical Biochemistry, Molecular Biology and Biotechnology Unit, Faculty of Medicine, Benha University, Al Qalyubia, Egypt
inas.ahmed@fmed.bu.edu.eg
Shuzan
Mohammed
Ali
Department of Medical Biochemistry, Molecular Biology and Biotechnology Unit, Faculty of Medicine, Benha University, Al Qalyubia, Egypt.
Hend
El-sayed
Departments of Medical Biochemistry,Faculty of Medicine, Benha University, Egypt.
36
1
1655
2016-06-01
2018-07-04
2016-06-01
42
52
1110-0842
2356-9514
https://besps.journals.ekb.eg/article_8644.html
https://besps.journals.ekb.eg/service?article_code=8644
5
Original Article
567
Journal
Bulletin of Egyptian Society for Physiological Sciences
https://besps.journals.ekb.eg/
MicroRNA expression in chronic Hepatitis C patients treated with combined pegylated interferon alpha and ribavirin therapy
Details
Type
Article
Created At
22 Jan 2023